Knockdown of nr2f1a causes defects in zebrafish vascular development. by Bao-Jueng Wu (621818)

“…At the same stage ISVs are stalled at mid-somite in nr2f1a^e2i2 morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a ∼50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”

Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies by Hong-Bo Guan (464993)

“…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”

Dengue and malaria spatio-temporal patterns in Loreto. by Gabriel Carrasco-Escobar (794055)

Poincaré maps for the best no-FIC (A1) and post-FIC (B1) MMF fit. by Jan Stasinski (20371167)

“…A decrease in number of nodes in a single regime or an increase in the number of nodes in two or three regimes is considered a richer repertoire of behaviors as a result of implementing dFIC.…”

Fitted parameter values shown session by session, and at a subsession resolution in the initial and final sessions. by Noémi Éltető (14197656)

“…<p>The grey band on the bottom of each plot shows the sequence that participants practiced: the old sequence in sessions 1–8 (dark grey), the new sequence in session 9 (light grey), and both sequences alternately in session 10. Point distance in (a) and cell width in (b) are proportional to data bin size—we fitted the model to 5 epochs within sessions 1, 9, and 10 to assess potentially fast shifts. …”

Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression by Christian Röver (790648)

“…<div><p>Background</p><p>Recent systematic reviews of randomised controlled trials (RCTs) in relapsing multiple sclerosis (RMS) revealed a decrease in placebo annualized relapse rates (ARR) over the past two decades. …”

S2 Data - by Tamara Mogilevski (14239682)

“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”

Study protocol. by Tamara Mogilevski (14239682)

“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”

S1 Data - by Tamara Mogilevski (14239682)

“…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”

Comparison of various inducer treatments on physiological and biochemical parameters in plants under drought conditions, relative to both drought-stressed and well-watered control... by Shelina Akter Sheuli (22446598)

Comparison of various inducer treatments on physiological and biochemical parameters in plants under normal conditions, relative to well-watered control plants. by Shelina Akter Sheuli (22446598)

Preliminary molecular characterization of a proinflammatory and nociceptive molecule from the Echinometra lucunter spines extracts by Juliana Mozer Sciani (4626790)

A LASSO-BASED DEA FOR ECO-EFFICIENCY PERFORMANCE ASSESSMENT FOR THE GLOBAL FOOD AND BEVERAGES INDUSTRY by SALAMEH, DOA'A MOHAMMAD FUAD

Get full text

Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease by Hossein Haddadi (4895290)

“…The 6-OHDA-lesioned rats showed contralateral rotations towards the lesion side, which was accompanied by learning and memory deficits in a passive avoidance test and a decrease in tail withdrawal latency in a tail flick test at the end of week 6. …”

Vibration–induced enhancement of stick balancing skill as a function of vibration-induced amplitude lowering. by John G. Milton (223908)

“…Data is obtained from three subjects using three different vibration frequencies (15 Hz, 25 Hz, 50 Hz) on three different days. Relative survival is the same as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007427#pone-0007427-g003" target="_blank">Figure 3</a>. …”

Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”

Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”

HBV Infection in Relation to Consistent Condom Use: A Population-Based Study in Peru by Antonio Bernabe-Ortiz (90790)

“…Consistent condom use was associated with decreased risk of anti-HBc. Findings from this study emphasize the need of primary prevention programs (vaccination) especially in the jungle population, and imply that condom use promotion might be a potential strategy to prevent HBV infection.…”

Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis by Wey-Ran Lin (615284)

“…We aimed to test the effect of G-CSF on fibrosis in a mouse model of CP.</p><p>Methods</p><p>CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 µg/kg/day, 2 days a week) for 6 weeks. …”

Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

“…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”